{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Narcolepsy+With+Cataplexy&page=2", "query": { "condition": "Narcolepsy With Cataplexy", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Narcolepsy+With+Cataplexy&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T13:19:42.576Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07455383", "title": "A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Narcolepsy Type 1" ], "interventions": [ { "name": "ALKS 2680 Dose 1", "type": "DRUG" }, { "name": "ALKS 2680 Dose 2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alkermes, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 150, "start_date": "2026-04-06", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 15, "location_summary": "Los Angeles, California • Boulder, Colorado • Brandon, Florida + 12 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Brandon", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Winter Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07455383" }, { "nct_id": "NCT06952699", "title": "A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy Type 2" ], "interventions": [ { "name": "TAK-360", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 88, "start_date": "2025-05-06", "completion_date": "2026-08-20", "has_results": false, "last_update_posted_date": "2026-05-27", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 31, "location_summary": "Auburn, Alabama • Chandler, Arizona • Chula Vista, California + 26 more", "locations": [ { "city": "Auburn", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06952699" }, { "nct_id": "NCT01093508", "title": "Single-dose Safety Study of APD916 in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Narcolepsy With or Without Cataplexy" ], "interventions": [ { "name": "APD916", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arena Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 72, "start_date": "2010-03", "completion_date": "2010-07", "has_results": false, "last_update_posted_date": "2010-11-02", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01093508" }, { "nct_id": "NCT05055024", "title": "An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy With Cataplexy", "Narcolepsy", "Narcolepsy Without Cataplexy" ], "interventions": [ { "name": "Mazindol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NLS Pharmaceutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 52, "start_date": "2021-10-26", "completion_date": "2023-01-19", "has_results": false, "last_update_posted_date": "2023-03-13", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Redwood City, California • San Diego, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Redwood City", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05055024" }, { "nct_id": "NCT05709873", "title": "Narcolepsy Nightmare Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Narcolepsy", "Narcolepsy Type 1", "Narcolepsy With Cataplexy", "Narcolepsy Type 2", "Narcolepsy Without Cataplexy" ], "interventions": [ { "name": "Imagery rehearsal therapy", "type": "BEHAVIORAL" }, { "name": "Targeted dream control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2023-02-22", "completion_date": "2024-04-30", "has_results": false, "last_update_posted_date": "2024-06-12", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05709873" }, { "nct_id": "NCT03881852", "title": "Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy", "Cataplexy Narcolepsy", "Excessive Sleepiness" ], "interventions": [ { "name": "AXS-12 (Reboxetine)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 21, "start_date": "2019-01-30", "completion_date": "2019-11-27", "has_results": true, "last_update_posted_date": "2023-08-24", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 14, "location_summary": "Birmingham, Alabama • Alameda, California • Santa Ana, California + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Alameda", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03881852" }, { "nct_id": "NCT00078312", "title": "Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Narcolepsy", "Sleep Apnea, Obstructive", "Sleep Apnea Syndromes", "Shift-Work Sleep Disorder" ], "interventions": [ { "name": "CEP-10953 (Armodafinil)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cephalon", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 328, "start_date": "2004-01", "completion_date": "2006-07", "has_results": true, "last_update_posted_date": "2013-07-19", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 41, "location_summary": "Peoria, Arizona • Phoenix, Arizona • Tucson, Arizona + 35 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00078312" }, { "nct_id": "NCT06358950", "title": "A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy Type 1" ], "interventions": [ { "name": "ALKS 2680", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alkermes, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 92, "start_date": "2024-03-28", "completion_date": "2025-07-31", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 29, "location_summary": "Los Angeles, California • Redwood City, California • San Francisco, California + 24 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06358950" }, { "nct_id": "NCT05687903", "title": "A Study of TAK-861 in Participants With Narcolepsy Type 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy Type 1" ], "interventions": [ { "name": "TAK-861", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "16 Years to 70 Years" }, "enrollment_count": 112, "start_date": "2023-01-09", "completion_date": "2023-12-14", "has_results": true, "last_update_posted_date": "2025-01-09", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 21, "location_summary": "Birmingham, Alabama • Redwood City, California • Santa Ana, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Redwood City", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05687903" }, { "nct_id": "NCT06383806", "title": "Decreasing Nightmares in Adults With Narcolepsy", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Narcolepsy", "Narcolepsy Type 1", "Narcolepsy With Cataplexy", "Narcolepsy Without Cataplexy", "Nightmare", "Nightmare Disorder With Associated Other Sleep Disorder" ], "interventions": [ { "name": "Imagery Rehearsal Therapy (IRT)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2026-04-01", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-06-10T13:19:42.576Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06383806" } ] }